🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested
This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-08-09
Trial ID
NCT04526288
This phase II trial studies the effect of adding pomalidomide to usual chem...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-08-24
Trial ID
NCT04802161
This phase I trial studies the best dose and side effects of liposomal cyta...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-05-21
Trial ID
NCT04915612
Treatments Being Tested
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2021-07-29
Trial ID
NCT04269213
Treatments Being Tested
Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2017-07-07
Trial ID
NCT03226418
This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-10-29
Trial ID
NCT03629171
Treatments Being Tested
This phase II trial studies the side effects and how well liposome-encapsul...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-11-07
Trial ID
NCT03672539
Treatments Being Tested
This phase Ib trial studies the best dose of gemtuzumab ozogamicin when giv...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2019-07-18
Trial ID
NCT03904251
Treatments Being Tested